检索结果-南通市图书馆

Consensus on the Diagnosis and Treatment of Melasma in china (2021 Version)

在线全文

学校读者我要写书评

暂无评论

International Journal of Dermatology and Venereology 2021年第3期4卷 133-139页

作者： Pigmentary Disorder Group,Combination of Traditional and Western Medicine Dermatology Research Center for Vitiligo,Chinese Society of Dermatology Working Group on Pigmentary Disorders,china Dermatologist Association Tian-Wen Gao Hua Gu Li He Tie-Chi Lei Ming Li Tie-Nan Li Chun-Ying Li Tong Lin Kuan-Hou Mu Cai-Xia Tu Hai Wen Ji-Yuan Wu Ai-E Xu Jun-Ling Zhang Zhi-Zhong Zhen 不详 department of Dermatology Xijing HospitalThe Fourth Military Medical UniversityXi’anShanxi 710032China department of Dermatology The First Affiliated Hospital of Kunming Medical UniversityKunmingYunnan 650032China Renmin Hospital of Wuhan University WuhanHubei 430000China department of Dermatology Zhongshan Hospital of Fudan UniversityShanghai 200000China department of Dermatology The 7th Municipal People’s Hospital in ShenyangShenyangLiaoning 110000China Hospital for Skin Diseases(Institute of Dermatology) Chinese Academy of Medical Sciences and Peking Union Medical CollegeNanjingJiangsu 210000China department of Dermatology The First Affiliated Hospital of Xi’an Jiaotong UniversityXi’anShanxi 710032China department of Dermatology The Second Affiliated Hospital of Dalian Medical UniversityShenyangDalian 116000China department of Dermatology Changzheng Hospital of Navy Medical UniversityShanghai 200000China department of Dermatology The First Hospital of Wuhan CityWuhanHubei 430000China department of Dermatology The Third People’s Hospital of HangzhouHangzhouZhejiang 310000China The Affiliated Hospital of Tianjin academy of Traditional Chinese Medicine Tianjing 300000China department of Dermatology Huashan Hospital of Fudan UniversityShanghai 20000China

The pathogenesis of melasma is believed to be related to heredity,sun exposure,sex hormones,and other *** mechanisms underlying the development of melasma include increased melanin synthesis,vascular proliferation within the skin lesions,inflammation,and skin barrier *** diagnosis of melasma is mainly based on clinical manifestations and noninvasive *** with recent research progress in melasma,the present consensus comprehensively elaborates the etiology,pathogenesis,clinical manifestations,staging,classification,diagnosis,and treatment of melasma to improve the diagnostic and therapeutic skills of Chinese dermatologists.

关键词： diagnosis expert consensus melasma therapy

Clinical practice guideline for transurethral plasmakinetic resection of prostate for benign prostatic hyperplasia(2021 Edition)

维普期刊数据库评论

在线全文

维普期刊数据库

学校读者我要写书评

暂无评论

Military Medical Research 2022年第5期9卷 515-533页

作者： Xian-Tao Zeng Ying-Hui Jin Tong-Zu Liu Fang-Ming Chen De-Gang Ding Meng Fu Xin-Quan Gu Bang-Min Han Xing Huang Zhi Hou Wan-Li Hu Xin-Li Kang Gong-Hui Li Jian-Xing Li Pei-Jun Li Chao-Zhao Liang Xiu-Heng Liu Zhi-Yu Liu Chun-Xiao Liu Jiu-Min Liu Guang-Heng Luo Yi Luo Wei-Jun Qin Jian-Hong Qiu Jian-Xin Qiu Xue-Jun Shang Ben-Kang Shi Fa Sun Guo-Xiang Tian Ye Tian Feng Wang Feng Wang Yin-Huai Wang Yu-Jie Wang Zhi-Ping Wang Zhong Wang Qiang Wei Min-Hui Xiao Wan-Hai Xu Fa-Xian Yi Chao-Yang Zhu Qian-Yuan Zhuang Li-Qun Zhou Xiao-Feng Zou Nian-Zeng Xing Da-Lin He Xing-Huan Wang 无 department of Urology Institute of UrologyZhongnan Hospital of Wuhan UniversityWuhan430071China Center for Evidence-Based and Translational Medicine Zhongnan Hospital of Wuhan UniversityWuhan430071China department of Urology Tianjin Third Central Hospital Affiliated To Nankai UniversityTianjin300170China department of Urology Henan Provincial People’s HospitalZhengzhou University People’s HospitalZhengzhou450003China department of Urology Beijing Tsinghua Changgung HospitalSchool of Clinical MedicineTsinghua UniversityBeijing102218China department of Urology China-Japan Union Hospital of Jilin UniversityChangchun130033China department of Urology Shanghai General HospitalShanghai Jiao Tong University School of MedicineShanghai200080China department of Urology Qinghai University Affiliated HospitalXi’ning810012China department of Urology People’s Hospital of Hainan ProvinceHainan Affiliated Hospital of Hainan Medical University HaikouHaikou570311China department of Urology Sir Run Run Shaw HospitalZhejiang University School of MedicineHangzhou310016China department of Urology General Hospital of Ningxia Medical UniversityYinchuan750003China department of Urology The First Affiliated Hospital of Anhui Medical UniversityHefei230022China department of Urology Renmin Hospital of Wuhan UniversityWuhan430060China department of Urology The Second Hospital of Dalian Medical UniversityDalian116023LiaoningChina department of Urology Zhujiang Hospital of Southern Medical UniversityGuangzhou510282China department of Urology Guangdong Provincial People’s HospitalGuangdong Academy of Medical SciencesGuangzhou510080China department of Urology Surgery Guizhou Province People’s HospitalGuiyang550002China department of Urology Xijing Hospital of Air Force Military Medical UniversityXi’an710032China department of Urology The 980St Hospital of the PLA Joint Logistics Support Force(Bethune International Peace Hospital of PLA)Shijiazhuang050082China department of Urology

Benign prostatic hyperplasia (BPH) is highly prevalent among older men, impacting on their quality of life, sexual function, and genitourinary health, and has become an important global burden of disease. Transurethral plasmakinetic resection of prostate (TUPKP) is one of the foremost surgical procedures for the treatment of BPH. It has become well established in clinical practice with good efficacy and safety. In 2018, we issued the guideline “2018 Standard Edition”. However much new direct evidence has now emerged and this may change some of previous recommendations. The time is ripe to develop new evidence-based guidelines, so we formed a working group of clinical experts and methodologists. The steering group members posed 31 questions relevant to the management of TUPKP for BPH covering the following areas: questions relevant to the perioperative period (preoperative, intraoperative, and postoperative) of TUPKP in the treatment of BPH, postoperative complications and the level of surgeons’ surgical skill. We searched the literature for direct evidence on the management of TUPKP for BPH, and assessed its certainty generated recommendations using the grade criteria by the European Association of Urology. Recommendations were either strong or weak, or in the form of an ungraded consensus-based statement. Finally, we issued 36 statements. Among them, 23 carried strong recommendations, and 13 carried weak recommendations for the stated procedure. They covered questions relevant to the aforementioned three areas. The preoperative period for TUPKP in the treatment of BPH included indications and contraindications for TUPKP, precautions for preoperative preparation in patients with renal impairment and urinary tract infection due to urinary retention, and preoperative prophylactic use of antibiotics. Questions relevant to the intraoperative period incorporated surgical operation techniques and prevention and management of bladder explosion. The application to different

关键词： Transurethral plasmakinetic resection of prostate Benign prostatic hyperplasia Recommendation Treatment Guideline

在线全文

学校读者我要写书评

暂无评论

食管鳞癌术后随访中国胸外科专家共识

中国胸心血管外科临床杂志 2022年第2期29卷 141-149页

作者：陈龙奇李小飞傅剑华赵松李印毛友生柳硕岩于振涛谭黎杰李辉韩泳涛陈椿康明强胡坚李志刚李鹤成张仁泉徐世东张临友蔡开灿中国医师协会胸外科医师分会中国医药教育协会胸外科专业委员会四川大学华西医院胸外科成都610041 空军军医大学唐都医院胸外科西安710038 中山大学肿瘤防治中心胸外科广州510060 郑州大学第一附属医院胸外科郑州450052 中国医学科学院肿瘤医院胸外科北京100021 福建省肿瘤医院胸外科福州350014 中国医学科学院肿瘤医院深圳医院胸外科广东深圳518116 复旦大学附属中山医院胸外科上海200032 首都医科大学附属北京朝阳医院胸外科北京100020 电子科技大学附属肿瘤医院(四川省肿瘤医院)胸外科成都610041 福建医科大学附属协和医院胸外科福州350001 浙江大学医学院附属第一医院普胸外科杭州310003 上海市胸科医院胸外科上海200030 上海交通大学医学院附属瑞金医院胸外科上海200025 安徽医科大学第一附属医院胸外科合肥230022 哈尔滨医科大学附属肿瘤医院胸外科哈尔滨150081 哈尔滨医科大学附属第二医院胸外科哈尔滨150081 南方医科大学南方医院胸外科广州510515 不详

外科手术是食管鳞癌最重要的治疗手段之一,术后随访是早期发现和治疗复发转移的有效方法,可提高患者的生活质量,改善预后。本共识旨在完善我国的食管鳞癌术后随访方案,为规范随访提供参考,进一步提高我国食管癌规范化诊疗水平。

关键词：食管鳞癌术后随访专家共识

Diagnosis and Treatment of Acne Inversa/Hidradenitis Suppurativa in china: An Expert Consensus Statement (2021 Version)

在线全文

学校读者我要写书评

暂无评论

International Journal of Dermatology and Venereology 2021年第2期4卷 100-108页

作者： Hong Fang Xing-Hua Gao Song-Mei Geng Heng Gu Jun Gu Li He Xian Jiang Hong-Zhong Jin Qiang Ju Xiao-Jing Kang Wei Lai Cheng-Xin Li Hang Li Heng-Jin Li Shan-Shan Li Yu-Zhen Li Qing Sun Juan Tao Baoxi Wang Gang Wang Xin-Feng Wu Lei-Hong Xiang Hong-Fu Xie Hao-Xiang Xu Jin-Hua Xu Yan Yan Zhi-Zhong Zheng department of Dermatology The First Affiliated Hospital of Zhejiang UniversityHangzhouZhejiang 310003China department of Dermatology No.1 Hospital of China Medical UniversityShenyangLiaoning 110001China department of Dermatology The Second Affiliated Hospital of Xi’an Jiaotong UniversityXi’anShaanxi 710061China Hospital for Skin Diseases(Institute of Dermatology) Chinese Academy of Medical Sciences and Peking Union Medical CollegeNanjingJiangsu 210042China department of Dermatology Shanghai Tenth People’s HospitalTongji University School of MedicineShanghai 200072China department of Dermatology First Affiliated Hospital of Kunming Medical UniversityKunmingYunnan 650032China department of Dermatology West China HospitalSichuan UniversityChengduSichuan 610041China department of Dermatology Peking Union Medical College HospitalChinese Academy of Medical Sciences and Peking Union Medical CollegeBeijing 100021China department of Dermatology Renji HospitalSchool of MedicineShanghai Jiaotong UniversityShanghai 200025China department of Dermatology People’s Hospital of Xinjiang Uygur Autonomous RegionUrumqiXinjiang 830001China department of Dermatology and Venereology The Third Affiliated HospitalSun Yat-sen UniversityGuangzhouGuangdong 510630China department of Dermatology First Medical Center of Chinese PLA General HospitalBeijing 100853China department of Dermatology and Venerology Peking University First HospitalBeijing 100034China department of Dermatology Hainan Hospital of PLA General HospitalSanyaHainan 572013China department of Dermatology and Venereology The First Hospital of Jilin UniversityChangchunJilin 130021China department of Dermatology Second Affiliated Hospital of Harbin Medical UniversityHarbinHeilongjiang 150086China department of Dermatology Qilu Hospital of Shandong UniversityJinanShandong 250012China department of Dermatology Affiliated Union HospitalTongji Medical CollegeHuazhong University of Science and TechnologyWuhanHubei 430022China De

Acne inversa/hidradenitis suppurativa is a chronic,recurrent,inflammatory skin disease that affects the pilosebaceous units,causinfollicular *** etiology and pathogenesis of acne inversa/hidradenitis suppurativa involves internal and external factors such as genetic susceptibility,inflammation and immunity,microorganisms,obesity,and *** inversa/hidradenitis suppurativa is difficult to treat,and the current aim of treatment is to control the frequency and duration of disease flares and improve the quality of *** protocols for acne inversa/hidradenitis suppurativa should be selected based on the disease severity *** treatments include antibiotics,retinoids,biologics,immunosuppressive agents,and antiandrogen *** treatments include surgery and laser/light *** consensus aims to further standardize the diagnosis and treatment procedures of acne inversa/hidradenitis suppurativa in china to facilitate its diagnosis and treatment.

关键词： acne inversa consensus diagnosis hidradenitis suppurativa therapy

在线全文

学校读者我要写书评

暂无评论

腓骨肌萎缩症外科治疗专家共识

中华骨与关节外科杂志 2022年第9期15卷 641-651页

作者：中华医学会骨科学分会足踝外科学组国际矫形与创伤外科学会中国部足踝外科学会中国医疗保健国际交流促进会骨科分会足踝外科学部中国研究型医院学会足踝医学专业委员会中国医师协会骨科医师分会足踝外科、基础研究与矫形学组王正义俞光荣张建中徐向阳李开南唐康来马昕胡勇陈兆军梁晓军苗旭东王旭宋卫东张奉琪徐海林武勇张晖高鹏曾参军曾宪铁钱敏祁印泽不详北京中医药大学第三附属医院骨科北京100029 同济大学附属同济医院骨科上海200065 首都医科大学附属北京同仁医院骨科北京100730 上海交通大学医学院附属瑞金医院骨科上海200025 成都大学附属医院骨科成都610081 陆军军医大学第一附属医院骨科重庆400038 复旦大学附属华山医院骨科上海200040 山东大学第二医院骨科济南250033 西安交通大学医学院附属红会医院骨科西安710000 浙江大学医学院附属第二医院骨科杭州310009 中山大学孙逸仙纪念医院骨科广州510120 河北医科大学第三医院骨科石家庄050051 北京大学人民医院骨科北京100044 北京积水潭医院骨科北京100035 四川大学华西医院骨科成都610041 中国医学科学院北京协和医学院北京协和医院骨科北京100730 南方医科大学第三附属医院骨科广州510630 天津大学天津医院骨科天津300211 中国医学科学院北京协和医学院北京协和医院神经科北京100730

腓骨肌萎缩症在我国已确定为罕见病。由于该病较为罕见,国内骨科界对其认识参差不齐,外科治疗缺乏循证医学的指导意见,欠缺规范化。为更好地认识与治疗该病,避免其并发症的发生,同时为获得更好的疗效,中华医学会骨科学分会足踝外科学组... 详细信息

腓骨肌萎缩症在我国已确定为罕见病。由于该病较为罕见,国内骨科界对其认识参差不齐,外科治疗缺乏循证医学的指导意见,欠缺规范化。为更好地认识与治疗该病,避免其并发症的发生,同时为获得更好的疗效,中华医学会骨科学分会足踝外科学组,国际矫形与创伤外科学会中国部足踝外科学会,中国医疗保健国际交流促进会骨科分会足踝外科学部,中国研究型医院学会足踝医学专业委员会,中国医师协会骨科医师分会足踝外科、基础研究与矫形学组联合邀请国内知名专家,参考国内外相关的最新研究成果,研究探讨了该病的病理特点、病程发展规律、检查流程与诊断标准,提出外科治疗的策略与方法,最终形成本共识,以促进我国在该领域的进一步研究和提高腓骨肌萎缩症的诊疗水平。

关键词：腓骨肌萎缩症共识外科治疗

中国移植器官保护专家共识(2022中文版)

在线全文

学校读者我要写书评

暂无评论

中华外科杂志 2022年第5期60卷 409-423页

作者：中国肝移植注册中心国家肝脏移植质控中心国家人体捐献器官获取质控中心国家骨科与运动康复临床研究中心中国医师协会器官移植医师分会移植器官质量控制专业委员会中国医院协会器官获取与分配工作委员会国家创伤医学中心器官保护专业委员会郑树森叶啟发唐佩福徐骁李建辉王彦峰谢海洋陈静瑜董念国 Mitesh Badiwala Roberto Vanin Pinto Ribeiro 殷浩辛立明张浩张建政霍枫杨家印杨洪吉泮辉李绍光贾俊君俞浩梁涵杨思佳乔银标罗佳李浩宇王浩刘鐘阳张里程胡潇逸吴昊胡逸青不详树兰(杭州)医院肝胆胰外科国家卫生与健康委员会多器官联合移植研究重点实验室中国医学科学院肝胆胰肿瘤诊治创新单元及器官移植诊治重点实验室(2019RU019)浙江省器官移植重点实验室济南微生态生物医学省实验室杭州310003 济南微生态生物医学省实验室杭州310003 武汉大学中南医院解放军总医院第四医学中心浙江大学医学院附属杭州市第一人民医院树兰(杭州)医院浙江大学医学院附属第一医院

器官移植是治疗终末期器官功能衰竭最有效的手段,公民逝世后自愿捐献器官是我国移植器官的唯一来源。在临床实践中,移植器官保护技术对提升移植器官质量,改善移植预后发挥重要作用。中国医师协会器官移植医师分会、中华医学会外科学分... 详细信息

器官移植是治疗终末期器官功能衰竭最有效的手段,公民逝世后自愿捐献器官是我国移植器官的唯一来源。在临床实践中,移植器官保护技术对提升移植器官质量,改善移植预后发挥重要作用。中国医师协会器官移植医师分会、中华医学会外科学分会器官移植学组及中国肝移植注册中心科学委员会组织专家,基于国内外移植器官保护的基础研究与临床实践,根据牛津循证医学证据分级和证据评价与推荐意见分级、制定和评价推荐意见系统,针对肝脏、肾脏、胰腺、小肠、心脏、肺脏移植器官编写了《中国移植器官保护专家共识(2016年)》[1]。在国家肝脏移植注册中心、国家创伤医学中心、国家人体捐献器官获取质控中心、国家骨科与运动康复临床研究中心及国家肝脏移植质控中心的支持下,结合近年来国内外器官移植及器官保护临床实践与研究进展进行总结,形成《中国移植器官保护专家共识(2022中文版)》(简称共识)。本版共识重点更新了相关器官获取、保存、转运、质量评估在临床实践中的技术进展及相应循证医学研究证据。此外,还增加了包括以肢体移植为主的复合组织移植的内容。本版共识中的器官保护策略旨在促进临床器官移植工作科学、规范的开展。

关键词：器官移植器官保存机械灌注器官保存液专家共识

在线全文

学校读者我要写书评

暂无评论

中国移植器官保护专家共识(2022版)

中华消化外科杂志 2022年第2期21卷 169-184页

作者：中国肝移植注册中心国家肝脏移植质控中心国家人体捐献器官获取质控中心国家骨科与运动康复临床研究中心中国医师协会器官移植医师分会移植器官质量控制专业委员会中国医院协会器官获取与分配工作委员会国家创伤医学中心器官保护专业委员会郑树森李建辉徐骁王彦峰谢海洋陈静瑜董念国 Mitesh Badiwala Roberto Vanin Pinto Ribeiro 殷浩海辛立明张浩张建政霍枫杨家印杨洪吉泮辉李绍光贾俊君俞浩梁涵杨思佳乔银标罗佳李浩宇王浩刘鐘阳张里程胡潇逸吴昊胡逸青不详树兰(杭州)医院肝胆胰外科国家卫生与健康委员会多器官联合移植研究重点实验室中国医学科学院肝胆胰肿瘤诊治创新单元及器官移植诊治重点实验室(2019RU019)浙江省器官移植重点实验室杭州310003 济南微生态生物医学省实验室济南250002 树兰(杭州)医院浙江大学医学院附属杭州市第一人民医院武汉大学中南医院浙江大学医学院附属第一医院无锡市人民医院华中科技大学同济医学院附属协和医院 Toronto General Hospital 海军军医大学附属长征医院上海大学解放军总医院第四医学中心解放军南部战区总医院四川大学华西医院四川省人民医院

器官移植是治疗终末期脏器功能衰竭最有效的手段,公民逝世后自愿捐献器官已成为我国移植器官的唯一来源。在临床实践中,移植器官保护技术对提升移植器官质量,改善受者预后发挥重要作用。中国医师协会器官移植医师分会、中华医学会外科... 详细信息

器官移植是治疗终末期脏器功能衰竭最有效的手段,公民逝世后自愿捐献器官已成为我国移植器官的唯一来源。在临床实践中,移植器官保护技术对提升移植器官质量,改善受者预后发挥重要作用。中国医师协会器官移植医师分会、中华医学会外科学分会移植学组及中国肝移植注册中心科学委员会组织专家,基于国内外移植器官保护的基础研究与临床实践,根据牛津循证医学证据分级和GRADE推荐意见系统,针对肝脏、肾脏、胰腺、小肠、心脏、肺脏移植器官编写了《中国移植器官保护专家共识(2016版)》(以下简称2016版共识)。2022年,在中国肝移植注册中心、国家肝脏移植质控中心、国家人体捐献器官获取质控中心、国家骨科与运动康复临床研究中心、国家创伤医学中心器官保护专业委员会等机构的支持下,结合近年来国内外器官移植及器官保护临床实践与研究进展进行总结,形成《中国移植器官保护专家共识(2022版)》(以下简称共识)。此共识重点更新了相关器官获取、保存、转运、质量评估在临床实践中的技术进展及相应循证医学研究证据。此外,增加了包括以肢体移植为主的复合组织移植内容。本共识中器官保护策略旨在促进临床器官移植工作科学、规范开展。

关键词：器官移植器官保护机械灌注器官保存液专家共识